Home > Insider Trading > Filing (0000899243-20-020562)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1693011	Inozyme Pharma Inc.	INZY	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1202793	Michael Powell	3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1245624	James Healy	3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1680194	Sofinnova Management X, L.l.c.	3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1680200	Sofinnova Venture Partners X, L.p.	3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1720685	Maha Katabi	3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-07-28	1,590,808	$0.00	1,590,808	No	4	C	Direct
Common Stock	Acquisiton	2020-07-28	437,500	$16.00	2,028,308	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-2 Convertible Preferred Stock	Disposition	2020-07-28	11,888,112	$0.00	1,590,808	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

On July 28, 2020, the Series A-2 Convertible Preferred Stock automatically converted into Common Stock on a 7.4730-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A-2 Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.